Reference : Quality of life predicts outcome of deep brain stimulation in early Parkinson disease
Scientific journals : Article
Human health sciences : Neurology
Systems Biomedicine
http://hdl.handle.net/10993/41916
Quality of life predicts outcome of deep brain stimulation in early Parkinson disease
English
Krüger, Rejko mailto [University of Luxembourg > Faculty of Science, Technology and Communication (FSTC) > Life Science Research Unit >]
EARLYSTIM study group []
Schuepbach, Michael [Département de Neurologie > Hôpital Pitié-Salpêtrière]
Deuschl, Gunther [Universitätsklinikum Giessen und Marburg (L.T.)]
5-Mar-2019
Neurology
Lippincott Williams & Wilkins
Yes (verified by ORBilu)
0028-3878
1526-632X
Hagerstown
MD
[en] Quality of Life ; Deep Brain Stimulation ; Parkinson's disease
[en] Objective Toinvestigatepredictorsforimprovementofdisease-specificqualityoflife(QOL)afterdeepbrainstimulation (DBS) of the subthalamic nucleus (STN) for Parkinson disease (PD) with early motor complications. Methods We performed a secondary analysis of data from the previously published EARLYSTIM study, a prospective randomizedtrialcomparingSTN-DBS(n= 124)tobestmedicaltreatment(n= 127)after2yearsfollow-up with disease-specific QOL (39-item Parkinson ’s Disease Questionnaire summary index [PDQ-39-SI]) as the primary endpoint. Linear regression analyses of the baseline characteristics age, disease duration, duration of motor complications, and disease severity measured at baseline with the Unified Parkinson’s Disease Rating Scale(UPDRS)(UPDRS-III“off”and“on”medications,UPDRS-IV)wereconductedtodeterminepredictors of change in PDQ-39-SI. Results PDQ-39-SIatbaselinewascorrelatedtothechangeinPDQ-39-SIafter24monthsinbothtreatmentgroups (p<0.05).Thehigherthebaselinescore(worseQOL)thelargertheimprovementinQOLafter24months. No correlation was found for any of the other baseline characteristics analyzed in either treatment group. Conclusion Impaired QOL as subjectively evaluated by the patient is the most important predictor of benefit in patients with PD and early motor complications, fulfilling objective gold standard inclusion criteria for STN-DBS. Our results prompt systematically including evaluation of disease-specific QOL when selecting patients with PD for STN-DBS.
http://hdl.handle.net/10993/41916
10.1212/WNL.0000000000007037
https://n.neurology.org/content/92/10/e1109
Open Access

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
NEUROLOGY2018902601_EarlyStim_Quality of Life (002).pdfPublisher postprint510.91 kBView/Open

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.